Department of Cancer Research
Our vision is to impact on patients’ life by advancing the fight against cancer. Based on strong scientific track-records, we focus on priority research areas and provide research expertise covering the most common and/or malignant cancer types representing a health burden in Luxembourg. The department also represents a state-of-the-art training ground for next generation cancer researchers and acts as a reference point for cancer research in Luxembourg.
Mission
The main mission of the Department of Cancer Research is to advance the treatment options of cancer and reduce the cancer burden within the Luxembourg population and beyond. We do so through research excellence in priority areas covering the basic, translational and clinical research landscape to foster personalised medicine programs. Our activities focus on difficult to treat cancers and our teams have dedicated expertise in cancer immunology, the tumour microenvironment, tumor metabolism and neuro-oncology. We explore the cellular and molecular mechanisms of tumor progression using a wide range of state-of-the-art technologies, including multimodal omics technologies (genomics, metabolomics…), advanced immunoprofiling analyses, as well as ex vivo and in vivo imaging modalities leveraging patient data and innovative patient-derived models for cancer research.
Director of department
Adjunct professor, University of Bergen, Norway
In 2019, Prof Niclou was appointed Director of the Department of Cancer Research at the Luxembourg Institute of Health.
CONTACTS
-
Lars
Geffers Departmental project manager -
Siu-Thinh
Ho Administrative assistant
NICLOU
- Cancer Metabolism Group
- Cytoskeleton and Cancer Progression
- DNA Repair and Chemoresistance
- In Vivo Imaging
- Luxembourg Centre of Neuropathology
- Multiomics Data Science
- NORLUX Neuro-Oncology Laboratory
- Neuro-Immunology Group
- Translational Radiomics
- Tumor Immunotherapy and Microenvironment
- Tumor Stroma Interactions
Projects & clinical trials
Featured team members
Within the Luxembourg Institute of Health, qualified professionals with various expertises are working together striving for excellence. Their talent, their ability to collaborate and the complementarity of their skills are some of the key elements allowing us to create societal and economical value.
Scientific publications
LIH researchers strive to generate meaningful and disease-relevant knowledge and results for patients. Their findings are regularly published in prestigious international peer-reviewed journals, thereby extending the reach and visibility of the institute’s impact.
Related News
-
LIH paves the way to revolutionise cancer immunotherapy through two EU funded projects
-
Think Pink Lux ‘Marian Aldred Award’ awarded to LIH researchers
-
Masters of Disguise: New tactics in the hunt for shapeshifting cancers
-
Advancing personalization of cancer radiotherapy treatment
-
Changing department names
-
Excellent Thesis Award for Hannah Wurzer
Forthcoming events
-
🇬🇧 AllergoOncology: The role of IgE in anti-tumor surveillance – lessons learned from IgE deficient patients
Lecture Series Cancer Research
Webinar
Speaker Dr Denisa E. Ferastraoaru
07/06/2022 16:15
-
🇫🇷 Roadmap for Translational Cancer Research in Luxembourg: a PNC2 initiative
Webinar
13/07/2022 19:00
CANBIO
CANBIO is a doctoral research and training unit (DTU) addressing the clinical problem of tumour progression and recurrence. PhD candidates within CANBIO are engaged in a collaborative and interdisciplinary endeavour to deliver novel insight into tumour escape mechanisms, disease monitoring and large scale data analysis in highly malignant cancers.
i2TRON
TTM is taking a leading role in the coordination of i2TRON, a doctoral training unit (DTU) with a strong focus on developing the new generation of translational scientists, who can turn observations in the laboratory, clinical setting or community into interventions that improve the health of individuals via innovative diagnostics or treatments.
Visit the dedicated webpage for more information:
